Lazard Asset Management’s Abiomed Inc ABMD Stock Holding History
Bought
Maintained
Sold
Other funds holding ABMD
TRSOTSOK
BTI
IA
AW
HNB
Lazard Asset Management's ABMD Position: Q4 2022 in Review
Lazard Asset Management sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 59,432 shares — an estimated $14.6M sold.
Lazard Asset Management first reported a position in ABMD in Q2 2015 and held it in 16 quarters. The position peaked at $14.6M in Q3 2022. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.
- Lazard Asset Management reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
- Lazard Asset Management sold 59,432 Abiomed Inc shares in Q4 2022, an estimated $14.6M.
- Lazard Asset Management first reported a position in Abiomed Inc in Q2 2015 and held it in 16 quarters.
- Lazard Asset Management's Abiomed Inc position peaked at $14.6M in Q3 2022.
- 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.
Based on Lazard Asset Management's 13F filing for Q4 2022, filed 15 Feb 2023.